SARS-CoV Spike anticorps (AA 1124-1140)
Aperçu rapide pour SARS-CoV Spike anticorps (AA 1124-1140) (ABIN199984)
Antigène
Voir toutes SARS-CoV Spike (SARS-CoV S) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1124-1140
-
Specificité
- Full length Spike protein transfected into UM92 cells was used as a positive control and an approximate 139 kD band was observed.
-
Purification
- Protein G purified
-
Immunogène
-
Type of Immunogen: Native protein
-
-
-
-
Indications d'application
- Approved: WB (5 μg/mL)
-
Commentaires
-
Target Species of Antibody: SARS Coronavirus
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, 0.2 % gelatin, 0.05 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." dans: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
-
: "A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters. ..." dans: Nature communications, Vol. 12, Issue 1, pp. 6277, (2021) (PubMed).
-
- SARS-CoV Spike (SARS-CoV S) (SARS-Coronavirus Spike Protein (SARS-CoV S))
-
Autre désignation
- SARS-CoV Spike
-
Classe de substances
- Viral Protein
-
Sujet
-
Name/Gene ID: S
Family: Virion Structure
Synonyms: S, E2, S E2 glycoprotein, E2 glycoprotein precursor -
ID gène
- 1489668
Antigène
-